Protective Effectiveness of Hantavirus Vaccine

A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overla...

Full description

Bibliographic Details
Main Authors:	Keeho Park, Chang Soo Kim, Ki-Tae Moon
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2004-12-01
Series:	Emerging Infectious Diseases
Subjects:	hantavirus vaccine hemorrhagic fever with renal syndrome effectiveness dispatch South Korea
Online Access:	https://wwwnc.cdc.gov/eid/article/10/12/04-0684_article

id	doaj-7c035b42c4fa4e739061c7334330a386
record_format	Article
spelling	doaj-7c035b42c4fa4e739061c7334330a3862020-11-24T21:45:43ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592004-12-0110122218222010.3201/eid1012.040684Protective Effectiveness of Hantavirus VaccineKeeho ParkChang Soo KimKi-Tae MoonA case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.https://wwwnc.cdc.gov/eid/article/10/12/04-0684_articlehantavirus vaccinehemorrhagic fever with renal syndromeeffectivenessdispatchSouth Korea
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Keeho Park Chang Soo Kim Ki-Tae Moon
spellingShingle	Keeho Park Chang Soo Kim Ki-Tae Moon Protective Effectiveness of Hantavirus Vaccine Emerging Infectious Diseases hantavirus vaccine hemorrhagic fever with renal syndrome effectiveness dispatch South Korea
author_facet	Keeho Park Chang Soo Kim Ki-Tae Moon
author_sort	Keeho Park
title	Protective Effectiveness of Hantavirus Vaccine
title_short	Protective Effectiveness of Hantavirus Vaccine
title_full	Protective Effectiveness of Hantavirus Vaccine
title_fullStr	Protective Effectiveness of Hantavirus Vaccine
title_full_unstemmed	Protective Effectiveness of Hantavirus Vaccine
title_sort	protective effectiveness of hantavirus vaccine
publisher	Centers for Disease Control and Prevention
series	Emerging Infectious Diseases
issn	1080-6040 1080-6059
publishDate	2004-12-01
description	A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.
topic	hantavirus vaccine hemorrhagic fever with renal syndrome effectiveness dispatch South Korea
url	https://wwwnc.cdc.gov/eid/article/10/12/04-0684_article
work_keys_str_mv	AT keehopark protectiveeffectivenessofhantavirusvaccine AT changsookim protectiveeffectivenessofhantavirusvaccine AT kitaemoon protectiveeffectivenessofhantavirusvaccine
_version_	1725904705538752512

Protective Effectiveness of Hantavirus Vaccine

Similar Items